A phase I study of the safety and immunogenicity of a multipeptide personalized genomic vaccine in the adjuvant treatment of solid cancers.
暂无分享,去创建一个
E. Schadt | E. Genden | W. Oh | M. Galsky | P. Dottino | A. Wolf | P. Friedlander | E. Port | H. Irie | S. Parekh | S. Gnjatic | N. Bhardwaj | B. Miles | M. Posner | A. Blázquez | J. Mandeli | R. Sabado | C. Kyi | H. Khorasani | H. Cho